A Phase II Randomized, Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 Compared with Investigator's Choice in HLA-A*0201 Positive Patients with Previously Untreated Advanced Uveal Melanoma
Clinical Trial Grant
Awarded By
Immunocore Limited
Start Date
October 25, 2017
End Date
August 9, 2025
Awarded By
Immunocore Limited
Start Date
October 25, 2017
End Date
August 9, 2025